Wells Fargo’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7K Sell
5,500
-4,500
-45% -$11.7K ﹤0.01% 5949
2025
Q4
$17.9K Buy
10,000
+5,000
+100% +$10.9K ﹤0.01% 5818
2025
Q3
$9.1K Sell
5,000
-1,826
-27% -$2.95K ﹤0.01% 5966
2025
Q2
$5.01K Sell
6,826
-38,894
-85% -$29.5K ﹤0.01% 6088
2025
Q1
$45.7K Sell
45,720
-24,933
-35% -$42.7K ﹤0.01% 5432
2024
Q4
$749K Buy
70,653
+13,196
+23% +$158K ﹤0.01% 3905
2024
Q3
$759K Sell
57,457
-1,023
-2% -$11.9K ﹤0.01% 3723
2024
Q2
$575K Buy
58,480
+23,537
+67% +$244K ﹤0.01% 3822
2024
Q1
$480K Buy
34,943
+7,588
+28% +$123K ﹤0.01% 3918
2023
Q4
$466K Buy
+27,355
New +$336K ﹤0.01% 3919

Other funds holding NMRA